Alector, Inc.: insider trading
477 trades by 28 directors, officers and 10% owners since 2019, from their SEC Form 4 and 5 filings.
Bought, 12 months
$0
0 purchases by 0 insiders
Sold, 12 months
$1.0 M
21 sales by 4 insiders
Bought, 3 months
$0
0 purchases
Sold, 3 months
$296 K
5 sales
Insider buying and selling by month
Open-market purchases and sales by value, last three years.
Insiders (28)
Each insider's latest direct holding and their open-market trades of the last 12 months, most recent first.
| Insider | Shares owned directly | Bought, 12 m | Sold, 12 m | Latest trade |
|---|---|---|---|---|
| Arnon RosenthalChief Executive Officer, Director | 2.51 M | — | $655 K | |
| Grace Wong-SaradPrincipal Accounting Officer | 161,570 | — | $99 K | |
| Neil Lindsay BerkleyCFO & Chief Business Officer | 395,216 | — | $221 K | |
| Elizabeth A. GarofaloDirector | 118,650 | — | — | |
| Errol B. DesouzaDirector | 98,650 | — | — | |
| Kristine YaffeDirector | 124,109 | — | — | |
| Louis J. Lavigne Jr.Director | 128,109 | — | — | |
| Mark AltmeyerDirector | 98,650 | — | — | |
| Paula HammondDirector | 103,609 | — | — | |
| Richard H. SchellerDirector | 134,899 | — | — | |
| Sara Kenkare-MitraPresident and Head of R&D | 501,652 | — | $47 K | |
| Marc GrassoChief Financial Officer | 296,072 | — | — | |
| Gary RomanoChief Medical Officer | 332,977 | — | — | |
| David M. WehnerDirector | 115,330 | — | — | |
| Polaris Venture Management Co. VI, L.L.C.10% owner | 0 | — | — | |
| Polaris Venture Partners VI (AIV), L.P.10% owner | 0 | — | — | |
| Terrance McGuireDirector, 10% owner | 54,996 | — | — | |
| Tillman U. GerngrossDirector | 2.64 M | — | — | |
| Robert KingChief Development Officer | 550,871 | — | — | |
| Shehnaaz SulimanPresident and COO | 102,598 | — | — | |
| Robert PaulChief Medical Officer | 234,319 | — | — | |
| Calvin YuVice President, Finance | 76,686 | — | — | |
| Orbimed Advisors LLC10% owner | — | — | — | |
| Sabah OneyChief Business Officer | 573,918 | — | — | |
| Orbimed Capital LLC10% owner | — | — | — | |
| OrbiMed Capital GP IV LLC10% owner | — | — | — | |
| Carl L. GordonDirector, 10% owner | — | — | — | |
| PVP VI (AIV) Feeder Corp. Holding Partnership, L.P.10% owner | — | — | — |
Trades#
| Traded | Insider | Trade | Shares | Price | Value | Owned after | Filing |
|---|---|---|---|---|---|---|---|
| filed | Grace Wong-SaradPrincipal Accounting Officer | Sell10b5-1 plan | -3,625 | $2.510 | $9 K | 106,015 | Form 4 |
| filed | Arnon RosenthalChief Executive Officer, Director | Sell | -72,606 | $2.660 | $193 K | 2.29 M | Form 4 |
| filed | Neil Lindsay BerkleyCFO & Chief Business Officer | Sell | -29,251 | $2.660 | $78 K | 350,649 | Form 4 |
| filed | Grace Wong-SaradPrincipal Accounting Officer | Sell | -5,165 | $2.670 | $14 K | 109,640 | Form 4 |
| filed | Grace Wong-SaradPrincipal Accounting Officer | Sell10b5-1 plan | -656 | $2.750 | $2 K | 114,805 | Form 4 |
| filed | Grace Wong-SaradPrincipal Accounting Officer | Sell10b5-1 plan | -3,475 | $1.880 | $7 K | 95,461 | Form 4 |
| filed | Grace Wong-SaradPrincipal Accounting Officer | Sell | -5,709 | $1.970 | $11 K | 98,936 | Form 4 |
| filed | Neil Lindsay BerkleyCFO & Chief Business Officer | Sell | -19,360 | $1.970 | $38 K | 379,900 | Form 4 |
| filed | Arnon RosenthalChief Executive Officer, Director | Sell | -87,216 | $1.970 | $172 K | 2.37 M | Form 4 |
| filed | Grace Wong-SaradPrincipal Accounting Officer | Sell10b5-1 plan | -1,820 | $2.650 | $5 K | 104,645 | Form 4 |
| filed | Grace Wong-SaradPrincipal Accounting Officer | Sell10b5-1 plan | -1,000 | $2.650 | $3 K | 106,465 | Form 4 |
| filed | Grace Wong-SaradPrincipal Accounting Officer | Sell10b5-1 plan | -3,367 | $2.080 | $7 K | 107,465 | Form 4 |
| filed | Neil Lindsay BerkleyCFO & Chief Business Officer | Sell | -29,649 | $2.120 | $63 K | 344,660 | Form 4 |
| filed | Grace Wong-SaradPrincipal Accounting Officer | Sell | -8,071 | $2.120 | $17 K | 110,832 | Form 4 |
| filed | Arnon RosenthalChief Executive Officer, Director | Sell | -81,864 | $2.120 | $174 K | 2.34 M | Form 4 |
| filed | Grace Wong-SaradPrincipal Accounting Officer | Sell10b5-1 plan | -4,079 | $2.500 | $10 K | 118,903 | Form 4 |
| filed | Grace Wong-SaradPrincipal Accounting Officer | Sell10b5-1 plan | -4,753 | $1.210 | $6 K | 122,982 | Form 4 |
| filed | Arnon RosenthalChief Executive Officer, Director | Sell | -104,347 | $1.120 | $117 K | 2.42 M | Form 4 |
| filed | Neil Lindsay BerkleyChief Bus Ofcr & Interim CFO | Sell | -37,261 | $1.120 | $42 K | 374,309 | Form 4 |
| filed | Grace Wong-SaradPrincipal Accounting Officer | Sell | -8,056 | $1.120 | $9 K | 127,735 | Form 4 |
| filed | Sara Kenkare-MitraPresident and Head of R&D | Sell | -41,687 | $1.120 | $47 K | 501,652 | Form 4 |
| filed | Neil Lindsay BerkleyPrincipal Financial Officer | Sell | -15,842 | $2.500 | $40 K | 346,570 | Form 4 |
| filed | Arnon RosenthalChief Executive Officer, Director | Sell | -51,562 | $2.500 | $129 K | 2.35 M | Form 4 |
| filed | Sara Kenkare-MitraPresident and Head of R&D | Sell | -23,638 | $2.500 | $59 K | 543,339 | Form 4 |
| filed | Grace Wong-SaradPrincipal Accounting Officer | Sell | -5,910 | $2.500 | $15 K | 103,448 | Form 4 |
| filed | Paula HammondDirector | Sell10b5-1 plan | -14,000 | $2.360 | $33 K | 74,909 | Form 4 |
| filed | Kristine YaffeDirector | Sell10b5-1 plan | -1,000 | $1.440 | $1 K | 95,409 | Form 4 |
| filed | Marc GrassoChief Financial Officer | Sell | -16,488 | $1.340 | $22 K | 296,072 | Form 4 |
| filed | Arnon RosenthalChief Executive Officer, Director | Sell | -52,087 | $1.340 | $70 K | 2.41 M | Form 4 |
| filed | Sara Kenkare-MitraPresident and Head of R&D | Sell | -23,890 | $1.340 | $32 K | 512,252 | Form 4 |
| filed | Gary RomanoChief Medical Officer | Sell | -16,306 | $1.470 | $24 K | 332,977 | Form 4 |
| filed | Sara Kenkare-MitraPresident and Head of R&D | Sell | -29,073 | $1.470 | $43 K | 536,142 | Form 4 |
| filed | Marc GrassoChief Financial Officer | Sell | -18,091 | $1.470 | $27 K | 312,560 | Form 4 |
| filed | Arnon RosenthalChief Executive Officer, Director | Sell | -40,330 | $1.470 | $59 K | 2.47 M | Form 4 |
| filed | Sara Kenkare-MitraPresident and Head of R&D | Sell | -26,500 | $2.520 | $67 K | 565,215 | Form 4 |
| filed | Gary RomanoChief Medical Officer | Sell | -14,892 | $2.520 | $38 K | 349,283 | Form 4 |
| filed | Arnon RosenthalChief Executive Officer, Director | Sell | -52,172 | $2.520 | $131 K | 2.51 M | Form 4 |
| filed | Marc GrassoChief Financial Officer | Sell | -16,489 | $2.520 | $42 K | 330,651 | Form 4 |
| filed | Marc GrassoChief Financial Officer | Sell | -7,297 | $4.880 | $36 K | 130,740 | Form 4 |
| filed | Gary RomanoChief Medical Officer | Sell | -8,478 | $4.880 | $41 K | 179,795 | Form 4 |
| filed | Sara Kenkare-MitraPresident and Head of R&D | Sell | -13,926 | $4.880 | $68 K | 291,715 | Form 4 |
| filed | Arnon RosenthalChief Executive Officer, Director | Sell | -26,499 | $4.880 | $129 K | 1.95 M | Form 4 |
| filed | Richard H. SchellerDirector | Sell | -44,250 | $5.160 | $228 K | 35,000 | Form 4 |
| filed | Kristine YaffeDirector | Sell10b5-1 plan | -5,000 | $5.060 | $25 K | 67,709 | Form 4 |
| filed | Paula HammondDirector | Sell10b5-1 plan | -10,500 | $5.060 | $53 K | 60,209 | Form 4 |
| filed | Arnon RosenthalChief Executive Officer, Director | Sell | -25,135 | $4.800 | $121 K | 1.98 M | Form 4 |
| filed | Marc GrassoChief Financial Officer | Sell | -6,920 | $4.800 | $33 K | 138,037 | Form 4 |
| filed | Sara Kenkare-MitraPresident and Head of R&D | Sell | -13,206 | $4.800 | $63 K | 305,641 | Form 4 |
| filed | Gary RomanoChief Medical Officer | Sell | -8,040 | $4.800 | $39 K | 188,273 | Form 4 |
| filed | Sara Kenkare-MitraPresident and Head of R&D | Sell | -10,169 | $6.920 | $70 K | 318,847 | Form 4 |
| filed | Marc GrassoChief Financial Officer | Sell | -5,716 | $6.920 | $40 K | 144,957 | Form 4 |
| filed | Arnon RosenthalChief Executive Officer, Director | Sell | -18,837 | $6.920 | $130 K | 2.00 M | Form 4 |
| filed | Gary RomanoChief Medical Officer | Sell | -6,001 | $6.920 | $42 K | 196,313 | Form 4 |
| filed | Sara Kenkare-MitraPresident and Head of R&D | Sell | -12,519 | $5.560 | $70 K | 329,016 | Form 4 |
| filed | Gary RomanoChief Medical Officer | Sell | -5,035 | $5.560 | $28 K | 202,314 | Form 4 |
| filed | Marc GrassoChief Financial Officer | Sell | -4,574 | $5.560 | $25 K | 150,673 | Form 4 |
| filed | Arnon RosenthalChief Executive Officer, Director | Sell | -23,831 | $5.560 | $133 K | 2.02 M | Form 4 |
| filed | Terrance McGuireDirector, 10% owner | Sellindirect | -500,000 | $6.000 | $3.0 M | 10.85 M | Form 4 |
| filed | Polaris Venture Management Co. VI, L.L.C.10% owner | Sellindirect | -500,000 | $6.000 | — | 10.85 M | Form 4 |
| filed | Marc GrassoChief Financial Officer | Sell | -1,114 | $5.190 | $6 K | 32,247 | Form 4 |
| filed | Gary RomanoChief Medical Officer | Sell | -2,771 | $5.190 | $14 K | 99,349 | Form 4 |
| filed | Arnon RosenthalChief Executive Officer, Director | Sell | -5,647 | $5.190 | $29 K | 1.65 M | Form 4 |
| filed | Sara Kenkare-MitraPresident and Head of R&D | Sell | -6,214 | $5.190 | $32 K | 177,935 | Form 4 |
| filed | Gary RomanoChief Medical Officer | Sell | -2,617 | $6.900 | $18 K | 102,120 | Form 4 |
| filed | Arnon RosenthalChief Executive Officer, Director | Sell | -5,255 | $6.900 | $36 K | 1.65 M | Form 4 |
| filed | Sara Kenkare-MitraPresident and Head of R&D | Sell | -4,092 | $6.900 | $28 K | 184,149 | Form 4 |
| filed | Marc GrassoChief Financial Officer | Sell | -1,050 | $6.900 | $7 K | 33,361 | Form 4 |
| filed | Arnon RosenthalChief Executive Officer, Director | Sell | -15,186 | $6.220 | $94 K | 1.66 M | Form 4 |
| filed | Sara Kenkare-MitraPresident and Head of R&D | Sell | -10,124 | $8.320 | $84 K | 188,241 | Form 4 |
| filed | Marc GrassoChief Financial Officer | Sell | -1,291 | $8.320 | $11 K | 34,411 | Form 4 |
| filed | Arnon RosenthalChief Executive Officer, Director | Sell | -5,849 | $8.320 | $49 K | 1.63 M | Form 4 |
| filed | Gary RomanoChief Medical Officer | Sell | -3,238 | $8.320 | $27 K | 104,737 | Form 4 |
| filed | Gary RomanoChief Medical Officer | Sell | -2,145 | $8.710 | $19 K | 107,975 | Form 4 |
| filed | Robert KingChief Development Officer | Sell | -176 | $10.62 | $2 K | 529,295 | Form 4 |
| filed | Gary RomanoChief Medical Officer | Sell | -2,177 | $10.62 | $23 K | 90,073 | Form 4 |
| filed | Robert KingChief Development Officer | Sell | -177 | $8.710 | $2 K | 529,471 | Form 4 |
| filed | Robert KingChief Development Officer | Sell | -287 | $15.57 | $4 K | 528,404 | Form 4 |
| filed | Shehnaaz SulimanPresident and COO | Sell10b5-1 plan | -64,102 | $21.16 | $1.4 M | 113,496 | Form 4 |
| filed | Shehnaaz SulimanPresident and COO | Sell10b5-1 plan | -10,898 | $21.73 | $237 K | 102,598 | Form 4 |
| filed | Shehnaaz SulimanPresident and COO | Sell10b5-1 plan | -66,126 | $21.69 | $1.4 M | 111,472 | Form 4 |
| filed | Shehnaaz SulimanPresident and COO | Sell10b5-1 plan | -8,874 | $22.33 | $198 K | 102,598 | Form 4 |
| filed | Shehnaaz SulimanPresident and COO | Sell10b5-1 plan | -72,357 | $22.80 | $1.6 M | 105,241 | Form 4 |
| filed | Shehnaaz SulimanPresident and COO | Sell10b5-1 plan | -2,643 | $23.40 | $62 K | 102,598 | Form 4 |
| filed | Shehnaaz SulimanPresident and COO | Sell10b5-1 plan | -36,511 | $22.56 | $824 K | 141,087 | Form 4 |
| filed | Shehnaaz SulimanPresident and COO | Sell10b5-1 plan | -38,489 | $23.01 | $886 K | 102,598 | Form 4 |
| filed | Robert KingChief Development Officer | Sell | -250 | $20.09 | $5 K | 528,691 | Form 4 |
| filed | Arnon RosenthalChief Executive Officer, Director | Sell10b5-1 plan · indirect | -55,000 | $25.00 | $1.4 M | 1.97 M | Form 4 |
| filed | Arnon RosenthalChief Executive Officer, Director | Sell10b5-1 plan · indirect | -55,000 | $25.00 | $1.4 M | 2.03 M | Form 4 |
| filed | Arnon RosenthalChief Executive Officer, Director | Sell10b5-1 plan · indirect | -55,000 | $25.00 | $1.4 M | 2.08 M | Form 4 |
| filed | Arnon RosenthalChief Executive Officer, Director | Sell10b5-1 plan · indirect | -15,000 | $25.00 | $375 K | 652,500 | Form 4 |
| filed | Arnon RosenthalChief Executive Officer, Director | Sell10b5-1 plan · indirect | -15,000 | $25.00 | $375 K | 652,500 | Form 4 |
| filed | Arnon RosenthalChief Executive Officer, Director | Sell10b5-1 plan · indirect | -15,000 | $25.00 | $375 K | 652,500 | Form 4 |
| filed | Arnon RosenthalChief Executive Officer, Director | Sell10b5-1 plan · indirect | -55,000 | $25.00 | $1.4 M | 2.14 M | Form 4 |
| filed | Arnon RosenthalChief Executive Officer, Director | Sell10b5-1 plan · indirect | -15,000 | $25.00 | $375 K | 667,500 | Form 4 |
| filed | Arnon RosenthalChief Executive Officer, Director | Sell10b5-1 plan · indirect | -15,000 | $25.00 | $375 K | 667,500 | Form 4 |
| filed | Arnon RosenthalChief Executive Officer, Director | Sell10b5-1 plan · indirect | -15,000 | $25.00 | $375 K | 667,500 | Form 4 |
| filed | Arnon RosenthalChief Executive Officer, Director | Sell10b5-1 plan · indirect | -55,000 | $25.00 | $1.4 M | 2.19 M | Form 4 |
| filed | Arnon RosenthalChief Executive Officer, Director | Sell10b5-1 plan · indirect | -15,000 | $25.00 | $375 K | 682,500 | Form 4 |
| filed | Arnon RosenthalChief Executive Officer, Director | Sell10b5-1 plan · indirect | -15,000 | $25.00 | $375 K | 682,500 | Form 4 |
| filed | Arnon RosenthalChief Executive Officer, Director | Sell10b5-1 plan · indirect | -15,000 | $25.00 | $375 K | 682,500 | Form 4 |
| filed | Arnon RosenthalChief Executive Officer, Director | Sell10b5-1 plan · indirect | -55,000 | $25.00 | $1.4 M | 2.25 M | Form 4 |
| filed | Arnon RosenthalChief Executive Officer, Director | Sell10b5-1 plan · indirect | -15,000 | $25.00 | $375 K | 697,500 | Form 4 |
| filed | Arnon RosenthalChief Executive Officer, Director | Sell10b5-1 plan · indirect | -15,000 | $25.00 | $375 K | 697,500 | Form 4 |
| filed | Arnon RosenthalChief Executive Officer, Director | Sell10b5-1 plan · indirect | -15,000 | $25.00 | $375 K | 697,500 | Form 4 |
| filed | Arnon RosenthalChief Executive Officer, Director | Sell10b5-1 plan · indirect | -9,625 | $25.10 | $242 K | 2.30 M | Form 4 |
| filed | Arnon RosenthalChief Executive Officer, Director | Sell10b5-1 plan · indirect | -94,717 | $25.29 | $2.4 M | 2.32 M | Form 4 |
| filed | Arnon RosenthalChief Executive Officer, Director | Sell10b5-1 plan · indirect | -5,283 | $26.10 | $138 K | 2.31 M | Form 4 |
| filed | Arnon RosenthalChief Executive Officer, Director | Sell10b5-1 plan · indirect | -91,538 | $26.07 | $2.4 M | 2.42 M | Form 4 |
| filed | Arnon RosenthalChief Executive Officer, Director | Sell10b5-1 plan · indirect | -8,462 | $26.56 | $225 K | 2.41 M | Form 4 |
| filed | Arnon RosenthalChief Executive Officer, Director | Sell10b5-1 plan · indirect | -91,954 | $25.76 | $2.4 M | 2.52 M | Form 4 |
| filed | Arnon RosenthalChief Executive Officer, Director | Sell10b5-1 plan · indirect | -8,046 | $26.33 | $212 K | 2.51 M | Form 4 |
| filed | Robert PaulChief Medical Officer | Sell10b5-1 plan | -22,650 | $27.17 | $615 K | 234,619 | Form 4 |
| filed | Robert PaulChief Medical Officer | Sell10b5-1 plan | -300 | $27.79 | $8 K | 234,319 | Form 4 |
| filed | Richard H. SchellerDirector | Sell | -52,868 | $27.64 | $1.5 M | 3,392 | Form 4 |
| filed | Richard H. SchellerDirector | Sell | -3,392 | $28.30 | $96 K | 0 | Form 4 |
| filed | Robert PaulChief Medical Officer | Sell10b5-1 plan | -4,900 | $37.41 | $183 K | 259,168 | Form 4 |
| filed | Robert PaulChief Medical Officer | Sell10b5-1 plan | -7,700 | $38.14 | $294 K | 251,468 | Form 4 |
| filed | Robert PaulChief Medical Officer | Sell10b5-1 plan | -17,149 | $39.32 | $674 K | 234,319 | Form 4 |
| filed | Robert PaulChief Medical Officer | Sell10b5-1 plan | -10,224 | $35.10 | $359 K | 254,095 | Form 4 |
| filed | Robert PaulChief Medical Officer | Sell10b5-1 plan | -3,600 | $35.95 | $129 K | 250,495 | Form 4 |
| filed | Robert PaulChief Medical Officer | Sell10b5-1 plan | -1,000 | $37.43 | $37 K | 249,495 | Form 4 |
| filed | Robert PaulChief Medical Officer | Sell10b5-1 plan | -3,581 | $38.55 | $138 K | 245,914 | Form 4 |
| filed | Robert PaulChief Medical Officer | Sell10b5-1 plan | -10,495 | $39.20 | $411 K | 235,419 | Form 4 |
| filed | Robert PaulChief Medical Officer | Sell10b5-1 plan | -1,100 | $40.01 | $44 K | 234,319 | Form 4 |
| filed | Calvin YuVice President, Finance | Sell10b5-1 plan | -3,334 | $34.65 | $116 K | 76,686 | Form 4 |
| filed | Richard H. SchellerDirector | Sell10b5-1 plan | -9,981 | $31.14 | $311 K | 0 | Form 4 |
| filed | Robert KingChief Development Officer | Sell10b5-1 plan | -60,000 | $31.14 | $1.9 M | 522,317 | Form 4 |
| filed | Calvin YuVice President, Finance | Sell10b5-1 plan | -90,840 | $31.14 | $2.8 M | 96,686 | Form 4 |
| filed | Calvin YuVice President, Finance | Sell10b5-1 plan | -20,000 | $40.02 | $800 K | 76,686 | Form 4 |
| filed | Robert PaulChief Medical Officer | Sell10b5-1 plan | -30,000 | $31.14 | $934 K | 234,319 | Form 4 |
| filed | Robert PaulChief Medical Officer | Sell10b5-1 plan | -26,726 | $22.23 | $594 K | 246,993 | Form 4 |
| filed | Robert PaulChief Medical Officer | Sell10b5-1 plan | -4,600 | $22.18 | $102 K | 273,719 | Form 4 |
| filed | Robert PaulChief Medical Officer | Sell10b5-1 plan | -30,000 | $22.07 | $662 K | 273,719 | Form 4 |
| filed | Robert PaulChief Medical Officer | Sell10b5-1 plan | -16,175 | $19.00 | $307 K | 276,719 | Form 4 |
| filed | Robert PaulChief Medical Officer | Sell10b5-1 plan | -2,200 | $19.89 | $44 K | 274,519 | Form 4 |
| filed | Robert PaulChief Medical Officer | Sell10b5-1 plan | -800 | $20.83 | $17 K | 273,719 | Form 4 |
| filed | Calvin YuVice President, Finance | Sell10b5-1 plan | -1,844 | $17.77 | $33 K | 126,686 | Form 4 |
| filed | Robert PaulChief Medical Officer | Sell10b5-1 plan | -14,975 | $18.14 | $272 K | 273,719 | Form 4 |
| filed | Robert PaulChief Medical Officer | Sell10b5-1 plan | -4,200 | $18.04 | $76 K | 273,719 | Form 4 |
| filed | Robert PaulChief Medical Officer | Sell10b5-1 plan | -22,255 | $19.19 | $427 K | 213,764 | Form 4 |
| filed | Robert PaulChief Medical Officer | Sell10b5-1 plan | -45 | $19.83 | $892 | 213,719 | Form 4 |
| filed | Robert PaulChief Medical Officer | Sell10b5-1 plan | -13,800 | $22.21 | $306 K | 213,719 | Form 4 |
| filed | Robert PaulChief Medical Officer | Sell10b5-1 plan | -24,490 | $22.85 | $560 K | 219,229 | Form 4 |
| filed | Robert PaulChief Medical Officer | Sell10b5-1 plan | -5,510 | $23.55 | $130 K | 213,719 | Form 4 |
| filed | Robert PaulChief Medical Officer | Sell10b5-1 plan | -19,175 | $18.12 | $347 K | 213,719 | Form 4 |
| filed | Robert PaulChief Medical Officer | Sell10b5-1 plan | -19,175 | $20.81 | $399 K | 213,719 | Form 4 |
| filed | Robert PaulChief Medical Officer | Sell10b5-1 plan | -27,308 | $18.00 | $492 K | 213,719 | Form 4 |
| filed | Robert PaulChief Medical Officer | Sell10b5-1 plan | -30,000 | $18.01 | $540 K | 213,719 | Form 4 |
| filed | Robert PaulChief Medical Officer | Sell10b5-1 plan | -8,567 | $18.00 | $154 K | 213,719 | Form 4 |
| filed | Robert PaulChief Medical Officer | Sell10b5-1 plan | -30,000 | $18.12 | $544 K | 213,719 | Form 4 |
| filed | Robert PaulChief Medical Officer | Sell10b5-1 plan | -9,622 | $22.94 | $221 K | 214,097 | Form 4 |
| filed | Robert PaulChief Medical Officer | Sell10b5-1 plan | -378 | $23.58 | $9 K | 213,719 | Form 4 |
| filed | Polaris Venture Partners VI (AIV), L.P.10% owner | Sellindirect | -4,377 | $31.54 | $138 K | 12.85 M | Form 4 |
| filed | Terrance McGuireDirector, 10% owner | Sellindirect | -4,377 | $31.54 | — | 12.85 M | Form 4 |
| filed | Robert PaulChief Medical Officer | Sell10b5-1 plan | -6,091 | $29.43 | $179 K | 227,628 | Form 4 |
| filed | Robert PaulChief Medical Officer | Sell10b5-1 plan | -3,909 | $29.90 | $117 K | 223,719 | Form 4 |
| filed | Calvin YuVice President, Finance | Sell10b5-1 plan | -1,043 | $31.04 | $32 K | 110,986 | Form 4 |
| filed | Calvin YuVice President, Finance | Sell10b5-1 plan | -300 | $32.02 | $10 K | 110,686 | Form 4 |
| filed | Robert KingChief Development Officer | Sell10b5-1 plan | -3,365 | $26.24 | $88 K | 488,952 | Form 4 |
| filed | Robert PaulChief Medical Officer | Sell10b5-1 plan | -1,900 | $26.15 | $50 K | 241,819 | Form 4 |
| filed | Robert PaulChief Medical Officer | Sell10b5-1 plan | -5,996 | $27.00 | $162 K | 235,823 | Form 4 |
| filed | Robert KingChief Development Officer | Sell10b5-1 plan | -8,632 | $27.02 | $233 K | 480,320 | Form 4 |
| filed | Robert KingChief Development Officer | Sell10b5-1 plan | -3,003 | $27.78 | $83 K | 477,317 | Form 4 |
| filed | Robert PaulChief Medical Officer | Sell10b5-1 plan | -2,104 | $27.78 | $58 K | 233,719 | Form 4 |
| filed | Orbimed Advisors LLC10% owner | Sellindirect | -47,097 | $23.53 | $1.1 M | 5.96 M | Form 4 |
| filed | Orbimed Advisors LLC10% owner | Sellindirect | -15,086 | $23.53 | $355 K | 1.91 M | Form 4 |
| filed | Robert PaulChief Medical Officer | Sell10b5-1 plan | -10,000 | $22.27 | $223 K | 243,719 | Form 4 |
| filed | Orbimed Advisors LLC10% owner | Sellindirect | -17,595 | $23.52 | $414 K | 6.00 M | Form 4 |
| filed | Orbimed Advisors LLC10% owner | Sellindirect | -5,636 | $23.52 | $133 K | 1.92 M | Form 4 |
| filed | Orbimed Advisors LLC10% owner | Sellindirect | -218,208 | $23.79 | $5.2 M | 6.02 M | Form 4 |
| filed | Orbimed Advisors LLC10% owner | Sellindirect | -69,893 | $23.79 | $1.7 M | 1.93 M | Form 4 |
| filed | Orbimed Advisors LLC10% owner | Sellindirect | -62,573 | $23.65 | $1.5 M | 6.24 M | Form 4 |
| filed | Orbimed Advisors LLC10% owner | Sellindirect | -20,041 | $23.65 | $474 K | 2.00 M | Form 4 |
| filed | Orbimed Advisors LLC10% owner | Sellindirect | -6,946 | $23.10 | $160 K | 6.30 M | Form 4 |
| filed | Orbimed Advisors LLC10% owner | Sellindirect | -2,224 | $23.10 | $51 K | 2.02 M | Form 4 |
| filed | Orbimed Advisors LLC10% owner | Sellindirect | -189,355 | $24.50 | $4.6 M | 6.31 M | Form 4 |
| filed | Orbimed Advisors LLC10% owner | Sellindirect | -60,645 | $24.50 | $1.5 M | 2.02 M | Form 4 |
| filed | Orbimed Advisors LLC10% owner | Sellindirect | -42,727 | $24.66 | $1.1 M | 6.50 M | Form 4 |
| filed | Orbimed Advisors LLC10% owner | Sellindirect | -13,684 | $24.66 | $337 K | 2.08 M | Form 4 |
| filed | Orbimed Advisors LLC10% owner | Sellindirect | -51,235 | $24.45 | $1.3 M | 6.54 M | Form 4 |
| filed | Orbimed Advisors LLC10% owner | Sellindirect | -16,409 | $24.45 | $401 K | 2.09 M | Form 4 |
| filed | Orbimed Advisors LLC10% owner | Sellindirect | -11,057 | $26.05 | $288 K | 6.59 M | Form 4 |
| filed | Orbimed Advisors LLC10% owner | Sellindirect | -3,541 | $26.05 | $92 K | 2.11 M | Form 4 |
| filed | Robert PaulChief Medical Officer | Sell10b5-1 plan | -1,481 | $21.57 | $32 K | 262,238 | Form 4 |
| filed | Robert PaulChief Medical Officer | Sell10b5-1 plan | -2,884 | $22.47 | $65 K | 259,354 | Form 4 |
| filed | Robert PaulChief Medical Officer | Sell10b5-1 plan | -5,459 | $23.49 | $128 K | 253,895 | Form 4 |
| filed | Robert PaulChief Medical Officer | Sell10b5-1 plan | -176 | $24.46 | $4 K | 253,719 | Form 4 |
| filed | Orbimed Advisors LLC10% owner | Sellindirect | -1.39 M | $26.00 | $36.1 M | 6.60 M | Form 4 |
| filed | Orbimed Advisors LLC10% owner | Sellindirect | -445,086 | $26.00 | $11.6 M | 2.11 M | Form 4 |
| filed | Orbimed Advisors LLC10% owner | Sellindirect | -38,808 | $26.00 | $1.0 M | 0 | Form 4 |
| filed | Robert KingChief Development Officer | Sell10b5-1 plan | -4,668 | $29.09 | $136 K | 502,649 | Form 4 |
| filed | Robert PaulChief Medical Officer | Sell10b5-1 plan | -3,000 | $29.07 | $87 K | 270,719 | Form 4 |
| filed | Robert KingChief Development Officer | Sell10b5-1 plan | -10,332 | $29.77 | $308 K | 492,317 | Form 4 |
| filed | Robert PaulChief Medical Officer | Sell10b5-1 plan | -7,000 | $29.74 | $208 K | 263,719 | Form 4 |
| filed | Sabah OneyChief Business Officer | Sell10b5-1 plan | -19,900 | $35.03 | $697 K | 573,918 | Form 4 |
| filed | Calvin YuVice President, Finance | Sell10b5-1 plan | -24,033 | $35.02 | $842 K | 110,686 | Form 4 |
| filed | Calvin YuVice President, Finance | Sell10b5-1 plan | -2,621 | $35.00 | $92 K | 124,494 | Form 4 |
| filed | Sabah OneyChief Business Officer | Sell10b5-1 plan | -100 | $35.00 | $4 K | 593,818 | Form 4 |
| filed | Robert PaulChief Medical Officer | Sell10b5-1 plan | -10,000 | $32.10 | $321 K | 273,719 | Form 4 |
| filed | Richard H. SchellerDirector | Sell10b5-1 plan | -10,000 | $29.67 | $297 K | 9,981 | Form 4 |
| filed | Calvin YuVice President, Finance | Sell10b5-1 plan | -63,541 | $30.04 | $1.9 M | 125,294 | Form 4 |
| filed | Sabah OneyChief Business Officer | Sell10b5-1 plan | -16,667 | $30.00 | $500 K | 593,918 | Form 4 |
| filed | David M. WehnerDirector | Buy | +20,000 | $25.00 | $500 K | 44,621 | Form 4 |
| filed | Robert PaulChief Medical Officer | Sell10b5-1 plan | -8,000 | $28.00 | $224 K | 273,719 | Form 4 |
| filed | Sabah OneyChief Business Officer | Sell10b5-1 plan | -14,467 | $25.05 | $362 K | 593,918 | Form 4 |
| filed | Robert PaulChief Medical Officer | Sell10b5-1 plan | -5,401 | $24.22 | $131 K | 274,318 | Form 4 |
| filed | Sabah OneyChief Business Officer | Sell10b5-1 plan | -2,200 | $25.21 | $55 K | 593,918 | Form 4 |
| filed | Robert PaulChief Medical Officer | Sell10b5-1 plan | -599 | $25.22 | $15 K | 273,719 | Form 4 |
| filed | Robert KingChief Development Officer | Sell10b5-1 plan | -3 | $22.01 | $66 | 507,317 | Form 4 |
| filed | Robert KingChief Development Officer | Sell10b5-1 plan | -14,997 | $22.01 | $330 K | 507,320 | Form 4 |
| filed | Robert PaulChief Medical Officer | Sell10b5-1 plan | -10,000 | $18.67 | $187 K | 273,719 | Form 4 |
| filed | Orbimed Capital LLC10% owner | Sellindirect | -286,787 | $19.50 | $5.6 M | 7.99 M | Form 4 |
| filed | Orbimed Capital LLC10% owner | Sellindirect | -91,818 | $19.50 | $1.8 M | 2.56 M | Form 4 |
| filed | Orbimed Capital LLC10% owner | Sellindirect | -1,392 | $19.50 | $27 K | 38,808 | Form 4 |
| filed | Orbimed Advisors LLC10% owner | Sellindirect | -7,275 | $18.60 | $135 K | 8.28 M | Form 4 |
| filed | Orbimed Advisors LLC10% owner | Sellindirect | -2,325 | $18.60 | $43 K | 2.65 M | Form 4 |
| filed | Orbimed Advisors LLC10% owner | Sellindirect | -1,200 | $18.60 | $22 K | 40,200 | Form 4 |
| filed | Orbimed Advisors LLC10% owner | Sellindirect | -48,324 | $19.59 | $947 K | 8.29 M | Form 4 |
| filed | Orbimed Advisors LLC10% owner | Sellindirect | -15,476 | $19.59 | $303 K | 2.65 M | Form 4 |
| filed | Orbimed Advisors LLC10% owner | Sellindirect | -8,000 | $19.59 | $157 K | 41,400 | Form 4 |
| filed | Orbimed Advisors LLC10% owner | Sellindirect | -63,535 | $19.82 | $1.3 M | 8.34 M | Form 4 |
| filed | Orbimed Advisors LLC10% owner | Sellindirect | -20,350 | $19.82 | $403 K | 2.67 M | Form 4 |
| filed | Orbimed Advisors LLC10% owner | Sellindirect | -10,400 | $19.82 | $206 K | 49,400 | Form 4 |
| filed | Orbimed Advisors LLC10% owner | Sellindirect | -230,721 | $19.66 | $4.5 M | 8.40 M | Form 4 |
| filed | Orbimed Advisors LLC10% owner | Sellindirect | -73,879 | $19.66 | $1.5 M | 2.69 M | Form 4 |
| filed | Orbimed Advisors LLC10% owner | Sellindirect | -37,900 | $19.66 | $745 K | 59,800 | Form 4 |
| filed | Orbimed Advisors LLC10% owner | Sellindirect | -642,807 | $18.52 | $11.9 M | 8.63 M | Form 4 |
| filed | Orbimed Advisors LLC10% owner | Sellindirect | -205,793 | $18.52 | $3.8 M | 2.76 M | Form 4 |
| filed | Orbimed Advisors LLC10% owner | Sellindirect | -105,500 | $18.52 | $2.0 M | 97,700 | Form 4 |
| filed | Robert PaulChief Medical Officer | Sell10b5-1 plan | -10,000 | $20.03 | $200 K | 283,719 | Form 4 |
| filed | Sabah OneyChief Business Officer | Sell10b5-1 plan | -6,810 | $20.13 | $137 K | 593,918 | Form 4 |
| filed | Sabah OneyChief Business Officer | Sell10b5-1 plan | -500 | $20.01 | $10 K | 593,918 | Form 4 |
| filed | Sabah OneyChief Business Officer | Sell10b5-1 plan | -2,300 | $20.07 | $46 K | 593,918 | Form 4 |
| filed | Sabah OneyChief Business Officer | Sell10b5-1 plan | -5,156 | $20.02 | $103 K | 593,918 | Form 4 |
| filed | Sabah OneyChief Business Officer | Sell10b5-1 plan | -1,500 | $20.00 | $30 K | 593,918 | Form 4 |
| filed | Calvin YuVice President, Finance | Sell10b5-1 plan | -1,315 | $18.31 | $24 K | 175,294 | Form 4 |
| filed | Robert PaulChief Medical Officer | Sell10b5-1 plan | -10,000 | $15.93 | $159 K | 293,719 | Form 4 |
| filed | Robert KingChief Development Officer | Sell10b5-1 plan | -7,500 | $15.92 | $119 K | 522,317 | Form 4 |
| filed | Robert PaulChief Medical Officer | Sell10b5-1 plan | -10,000 | $14.68 | $147 K | 301,719 | Form 4 |
| filed | Sabah OneyChief Business Officer | Sell10b5-1 plan | -400 | $20.00 | $8 K | 593,918 | Form 4 |
| filed | Robert PaulChief Medical Officer | Sell10b5-1 plan | -4,000 | $20.00 | $80 K | 311,719 | Form 4 |
| filed | Robert PaulChief Medical Officer | Sell10b5-1 plan | -10,000 | $19.08 | $191 K | 311,719 | Form 4 |
| filed | Robert PaulChief Medical Officer | Sell10b5-1 plan · amended | -916 | $16.00 | $15 K | 323,719 | Form 4/A |
| filed | Robert PaulChief Medical Officer | Sell10b5-1 plan | -916 | $16.00 | $15 K | 321,719 | Form 4 |
| filed | Robert PaulChief Medical Officer | Sell10b5-1 plan · amended | -1,084 | $16.00 | $17 K | 323,719 | Form 4/A |
| filed | Robert KingChief Development Officer | Sell10b5-1 plan | -7,500 | $15.00 | $113 K | 529,817 | Form 4 |
| filed | Robert PaulChief Medical Officer | Sell10b5-1 plan | -1,084 | $16.00 | $17 K | 322,635 | Form 4 |
| filed | Robert PaulChief Medical Officer | Sell10b5-1 plan | -10,000 | $14.19 | $142 K | 323,719 | Form 4 |
| filed | OrbiMed Capital GP IV LLC10% owner | Sellindirect | -492,364 | $17.90 | $8.8 M | 9.27 M | Form 4 |
| filed | OrbiMed Capital GP IV LLC10% owner | Sellindirect | -157,636 | $17.90 | $2.8 M | 2.97 M | Form 4 |
| filed | Carl L. GordonDirector, 10% owner | Buyindirect | +157,939 | $19.00 | $3.0 M | 10.43 M | Form 4 |
| filed | Orbimed Advisors LLCDirector, 10% owner | Buyindirect | +157,939 | $19.00 | — | 10.43 M | Form 4 |
| filed | Orbimed Advisors LLCDirector, 10% owner | Buyindirect | +50,561 | $19.00 | — | 2.46 M | Form 4 |
| filed | Carl L. GordonDirector, 10% owner | Buyindirect | +50,561 | $19.00 | $961 K | 2.46 M | Form 4 |
| filed | Carl L. GordonDirector, 10% owner | Buyindirect | +203,200 | $19.00 | $3.9 M | 203,200 | Form 4 |
| filed | Orbimed Advisors LLCDirector, 10% owner | Buyindirect | +203,200 | $19.00 | — | 203,200 | Form 4 |